4//SEC Filing
ADAR1 Partners, LP 4
Accession 0001940272-24-000006
CIK 0001583648other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 6:48 PM ET
Size
11.5 KB
Accession
0001940272-24-000006
Insider Transaction Report
Form 4
ADAR1 Capital Management, LLC
10% Owner
Transactions
- Purchase
Common Stock
2024-08-09$14.89/sh+3,000$44,679→ 127,331 total(indirect: By: ADAR1 Partners) - Purchase
Common Stock
2024-08-12$15.88/sh+2,243$35,624→ 129,574 total(indirect: By: ADAR1 Partners) - Purchase
Common Stock
2024-08-12$15.88/sh+757$12,023→ 15,067 total(indirect: By LLC)
ADAR1 Partners, LP
10% Owner
Transactions
- Purchase
Common Stock
2024-08-09$14.89/sh+3,000$44,679→ 127,331 total(indirect: By: ADAR1 Partners) - Purchase
Common Stock
2024-08-12$15.88/sh+2,243$35,624→ 129,574 total(indirect: By: ADAR1 Partners) - Purchase
Common Stock
2024-08-12$15.88/sh+757$12,023→ 15,067 total(indirect: By LLC)
Footnotes (3)
- [F1]ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by ADAR1 Partners, LP ("ADAR1 Partners"). Because of the relationship between ADAR1 Partners and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by ADAR1 Partners.
- [F2]ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by Spearhead Insurance Solutions IDF, LLC - Series ADAR1 ("Spearhead"). Because of the relationship between Spearhead and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by Spearhead.
- [F3]For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001758866
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 6:48 PM ET
- Size
- 11.5 KB